Arkolith/Insider Trading/SYRS/Form 4

Chee Conley

President & CEO, DirectorSyros Pharmaceuticals, Inc. (SYRS) · full profile →Form 4 · filed Sep 12, 2024
Net Buying
Open-Market Buys
$161K
Open-Market Sells
$0
Net Open-Market Flow
$161K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 11, 2024Buy(P)50K$1.71$86K123K
Sep 10, 2024Buy(P)50K$1.51$76K73K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-105994) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML